[(3-Bromo-phenylamino)-phosphono-methyl]-phosphonic acid

ID: ALA370662

PubChem CID: 5277481

Max Phase: Preclinical

Molecular Formula: C7H10BrNO6P2

Molecular Weight: 346.01

Molecule Type: Small molecule

Names and Identifiers

Synonyms: (3-Bromophenylamino)Methylenediphosphonic Acid | CHEMBL370662|(3-Bromophenylamino)Methylenediphosphonic Acid|BDBM50173799|[(3-bromoanilino)-phosphono-methyl]phosphonic acid|(3-bromo-phenyl)-aminomethylene-1,1-bisphosphonate|[(3-Bromo-phenylamino)-phosphono-methyl]-phosphonic acid|Phosphonic acid, [[(3-bromophenyl)amino]methylene]bis-

Canonical SMILES:  O=P(O)(O)C(Nc1cccc(Br)c1)P(=O)(O)O

Standard InChI:  InChI=1S/C7H10BrNO6P2/c8-5-2-1-3-6(4-5)9-7(16(10,11)12)17(13,14)15/h1-4,7,9H,(H2,10,11,12)(H2,13,14,15)

Standard InChI Key:  SYHPXVAOJHTCRU-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 17 17  0  0  0  0  0  0  0  0999 V2000
   13.0146   -0.4738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0134   -1.2989    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7263   -1.7107    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4409   -1.2985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4380   -0.4701    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7245   -0.0620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1574   -0.0520    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.1545    0.7750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4397    1.1884    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
   15.8651    1.1883    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
   16.5851    1.6014    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.7220    1.6013    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.8550    1.9074    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.0232    0.4695    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.2792    0.4695    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.2936   -0.0459    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
   15.8585    2.0114    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  8  9  1  0
  4  5  1  0
  8 10  1  0
  2  3  1  0
 10 11  2  0
  5  6  2  0
  9 12  2  0
  6  1  1  0
  9 13  1  0
  1  2  2  0
  9 14  1  0
  5  7  1  0
 10 15  1  0
  3  4  2  0
  1 16  1  0
  7  8  1  0
 10 17  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA370662

   (3-Bromophenylamino)Methylenediphosphonic Acid

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 346.01

Molecular Weight (Monoisotopic): 344.9167

AlogP: 1.50

#Rotatable Bonds: 4

Polar Surface Area: 127.09

Molecular Species: ACID

HBA: 3

HBD: 5

#RO5 Violations: ┄

HBA (Lipinski): 7

HBD (Lipinski): 5

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 0.95

CX Basic pKa: ┄

CX LogP: 0.84

CX LogD: -3.98

Aromatic Rings: 1

Heavy Atoms: 17

QED Weighted: 0.52

Np Likeness Score: -0.62

References

1. Kotsikorou E, Song Y, Chan JM, Faelens S, Tovian Z, Broderick E, Bakalara N, Docampo R, Oldfield E..  (2005)  Bisphosphonate inhibition of the exopolyphosphatase activity of the Trypanosoma brucei soluble vacuolar pyrophosphatase.,  48  (19): [PMID:16162013] [10.1021/jm058220g]

2. Hudock MP, Sanz-Rodríguez CE, Song Y, Chan JM, Zhang Y, Odeh S, Kosztowski T, Leon-Rossell A, Concepción JL, Yardley V, Croft SL, Urbina JA, Oldfield E..  (2006)  Inhibition of Trypanosoma cruzi hexokinase by bisphosphonates.,  49  (1): [PMID:16392806] [10.1021/jm0582625]

3. Sanz-Rodríguez CE, Concepción JL, Pekerar S, Oldfield E, Urbina JA..  (2007)  Bisphosphonates as inhibitors of Trypanosoma cruzi hexokinase: kinetic and metabolic studies.,  282  (17): [PMID:17329254] [10.1074/jbc.m607286200]

4. Song Y, Chan JM, Tovian Z, Secrest A, Nagy E, Krysiak K, Bergan K, Parniak MA, Oldfield E..  (2008)  Bisphosphonate inhibitors of ATP-mediated HIV-1 reverse transcriptase catalyzed excision of chain-terminating 3'-azido, 3'-deoxythymidine: a QSAR investigation.,  16  (19): [PMID:18789701] [10.1016/j.bmc.2008.08.047]

5. Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P..  (2013)  Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,  21  (21): [PMID:24071448] [10.1016/j.bmc.2013.08.054]

6. Tauro M, Loiodice F, Ceruso M, Supuran CT, Tortorella P..  (2014)  Arylamino bisphosphonates: potent and selective inhibitors of the tumor-associated carbonic anhydrase XII.,  24  (8): [PMID:24650641] [10.1016/j.bmcl.2014.03.001]

7. Vermelho AB, Capaci GR, Rodrigues IA, Cardoso VS, Mazotto AM, Supuran CT..  (2017)  Carbonic anhydrases from Trypanosoma and Leishmania as anti-protozoan drug targets.,  25  (5): [PMID:28161253] [10.1016/j.bmc.2017.01.034]

8. Lacbay CM, Menni M, Bernatchez JA, Götte M, Tsantrizos YS..  (2018)  Pharmacophore requirements for HIV-1 reverse transcriptase inhibitors that selectively "Freeze" the pre-translocated complex during the polymerization catalytic cycle.,  26  (8): [PMID:29478802] [10.1016/j.bmc.2018.02.017]

Source

Source(1):

• Scientific Literature